Accuracy enhancement of metabolic index-based blood glucose estimation with a screening process for low-quality data.


Journal

Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 01 08 2024
revised: 08 10 2024
accepted: 08 10 2024
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: ppublish

Résumé

Many researchers have proposed various non-invasive glucose monitoring (NIGM) approaches using wearable or portable devices. However, due to the limited capacity of detectors for such compact devices and the movement of the body during measurement, the precision of the acquired data frequently diminishes, which can cause problems during actual use in daily life. In addition, intensive smoothing is often used in post-processing to mitigate the effects of erroneous values. However, this requires a considerable amount of data and results in a delay in the response to the actual blood glucose level (BGL). Instead of just applying data smoothing in the post-process of the data acquisition, we propose an active low-quality data screening method in the pre-process. In the proposal phase of the screening process, we employ an analytical approach to examine and formulate factors that might affect the BGL estimation accuracy. A signal quality index inspired by the standard deviation concept is introduced to detect visually apparent noise on signals. Furthermore, the total estimation error in the metabolic index (MI) is calculated based on potential perturbations defined by the signal-to-noise ratio (SNR) and the uncertainty due to discrete sampling. Thereafter, the acquired data were screened by these quality indices. By applying the proposed data screening process to the data obtained from a commercially available smartwatch device in the pre-process, the estimation accuracy of the MI-based BGL was improved significantly. Adopting the proposed screen process improves BGL estimation accuracy in the smartwatch-based prototype. Applying the proposed screen process will facilitate the integration of wearable and continuous BGL monitoring into size- and SNR-limited devices such as smartwatches and smart rings.

Identifiants

pubmed: 39464244
doi: 10.1117/1.JBO.29.10.107001
pii: 240216GRR
pmc: PMC11503645
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107001

Informations de copyright

© 2024 The Authors.

Auteurs

Tomoya Nakazawa (T)

Hamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.

Keiji Morishita (K)

Hamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.

Anna Ienaka (A)

Hamamatsu Photonics K.K., Intellectual Property Headquarters, Hamamatsu, Japan.

Takeo Fujii (T)

Hamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.

Masaki Ito (M)

Hamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.

Fumie Matsushita (F)

Hamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH